Skip to main content
Home

What's new in cardiac imaging? 2 experts discuss the latest trends

To hear about key trends in cardiac imaging, Cardiovascular Business spoke with two experts in cardiac imaging at American College of Cardiology (ACC) 2023 meeting, Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, and Rob Beanlands, MD, is director of the National Cardiac PET Centre at the University of Ottawa Heart Institute, Canada.

Marcelo DiCarli, MD, and Rob Beanlands, MD, shared their thoughts on the current state of cardiac imaging at ACC.23. 

  • Read more about What's new in cardiac imaging? 2 experts discuss the latest trends

Report: Top 10 reasons nurses resign

nurse.jpg
Photo by Andrea Piacquadio via Pexels

Up to 31% of nurses intend to leave their current patient care position within the next year, according to survey results published by McKinsey and Co.

  • Read more about Report: Top 10 reasons nurses resign

FDA expands dapagliflozin approval to cover all heart failure patients

older male patient and doctor

The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF

  • Read more about FDA expands dapagliflozin approval to cover all heart failure patients

Novavax to cut 25% of its workforce, with R&D taking the biggest hit

layoffs staff cuts termination workforce

Although the vaccine maker previously cut expenses by $50 million without laying off staff, the measures were not enough to keep pace with the effects of the COVID-19 global health emergency. 

  • Read more about Novavax to cut 25% of its workforce, with R&D taking the biggest hit

USPSTF recommends women begin breast cancer screening at 40, boosting stocks at mammo-related firms

Artificial intelligence can help make breast cancer screening mammography more accurate.

The draft update marks a shift from the task force's previous guidelines, which had endorsed screening beginning at age 50.

  • Read more about USPSTF recommends women begin breast cancer screening at 40, boosting stocks at mammo-related firms

Shockwave Medical announces huge Q1 growth, including skyrocketing revenue, amid Boston Scientific rumors

Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.

The company reported a Q1 revenue of $161.1 million, up 72% from Q1 in 2022. Both gross profit and net income were also up considerably when compared to 2022. 

  • Read more about Shockwave Medical announces huge Q1 growth, including skyrocketing revenue, amid Boston Scientific rumors

Industry Watcher’s Digest

heart health attack cardiology

Buzzworthy developments of the past few days.

  • Read more about Industry Watcher’s Digest

$140M in federal funds primed to advance AI across 7 realms

National Science Foundation AI Institutes

Image by Florian Krumm via Unsplash

The National Science Foundation (NSF) is setting up seven new institutes for studying foundational AI. Two of the initiatives have healthcare as a prime focus.

  • Read more about $140M in federal funds primed to advance AI across 7 realms

ChatGPT helps radiologist churn out 16 papers in 4 months

ChatGPT chatbot

Image by Alexandra Koch via Pixabay

“Healthcare is going to change. Writing is going to change. Research is going to change. I’m just trying to publish now and show it so people can know about it and explore more.” 

  • Read more about ChatGPT helps radiologist churn out 16 papers in 4 months

Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD trial prsented at SCAI 2022. #DisruptPAD, #DisruptCAD, #SCAI #SCAI22 #SCAI2022
Image courtesy of Shockwave Medical.

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical. 

  • Read more about Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …866
    • Page 867
    • Page 868
    • Page 869
    • Current page 870
    • Page 871
    • Page 872
    • Page 873
    • Page 874 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme